Systematic Reviews
Copyright ©The Author(s) 2021.
World J Transplant. Nov 18, 2021; 11(11): 480-502
Published online Nov 18, 2021. doi: 10.5500/wjt.v11.i11.480
Table 2 Native kidney biopsy outcomes of acute tubular injury and necrosis in coronavirus disease 2019 cases
Ref.
Age
Sex
Ethnicity
Comorbidities
Renal presentation
Baseline creatinine (mg/dL)
Presentation Creatinine (mg/dL)
Presentation proteinuria (g/day)
Presentation albumin (g/L)
Treatment received
Outcome (renal and survival)
RRT needed
Time to biopsy
Haematuria
Sharma et al[14]62MHispanicT2DMAKI and proteinuria-1.23 -Steroid, HCQ, anakinra, plasmaDiedYes-Yes
Sharma et al[14] 69MHispanicHTNAKI, proteinuria, anti-cardiolipin positive-0.92.4-Steroid, HCQ, anakinra, plasmaDiedYes-Yes
Sharma et al[14]76FCaucasianT2DM, HTN Severe AKI and Proteinuria-1 (peak 4.4)0.9 -NoneDINo-No
Sharma et al[14]59MBlack HTN, CCFAKI, Proteinuria and raised K:L ratio-4.5 (peak 6)2.8-NoneDINo-Yes
Sharma et al[14]69FBlackHTN, HyperlipidaemiaAKI NRP-1.97.6-SteroidsDDYes-No
Kudose et al[13] 43FBlackT2DM, HLD, streptococcal infection, obesity (BMI 52.5)AKI-3.5 (peak 6.7)1-NoneDDYes-Yes
Kudose et al[13] 67MCaucasianHTN, Gout, ObeseAKI on CKD - 5.7 0.3 -Tocilizumab, HCQ, azithromycinDDYes-Yes
Kudose et al[13] 51MBlack HTN, AF, HLD, CVA, BPH AKI on CKD 1.84.80.5-HCQDINo -Yes
Akilesh et al[17] 34FCaucasianHTN, T2DMAKI NS -1.2 7--DINoDay 4No
Akilesh et al[17] 67FHispanic HTNAKI-1.41--DINoDay 5Yes
Lenti et al[31]25MCaucasian-AKI NS -3.80.48------
Rossi et al[32] 49MCaucasianObesity AKI----HCQ, Lopinavir/RitonavirDIRequired when in hospital--
Papadimitriou et al[33]52M-HIV, HTN, coronary artery disease, Factor V deficiencyAKINormal7.51.85--DDYesDay 10-
Papadimitriou et al[33]64M-AF, hyperlipidaemia, goutAKI11.4--I&V, IV heparin then apixaban (AF), 4 units blood following haematemesis, meropenem (E. coli in sputum), RRT day 22 to 33, MRSA > linezolidDIYesDay 84-